Buy Cipla, says A Dalal

Amit Dalal of Amit Nalin Securities is of the view that one can buy Cipla.

Dalal told CNBC-TV18, "I would buy a Cipla because last year they had a very bad year, this year there is a turnaround in it. Also after seeing Ranbaxy I think that perhaps if not this year at some point of time we will have another Ranbaxy coming from Cipla in terms of finding a Daiichi Sankyo. So Cipla to me makes a very good investment call at these levels."

Disclosure: It is safe to assume that analyst and his clients may have an investment interest in the above stock/sector.